Skip to main content


October 09, 2020
Individuals with severe mental illness are at increased risk for weight gain due to side effects from atypical antipsychotics and mood stabilizers, sedentary lifestyle, and social isolation. Obesity is a known risk factor for developing depression and their bidirectional relationship warrants…
October 09, 2020
Objective: This real-world retrospective cohort study evaluated healthcare resource utilization (HCRU) and costs for adult patients with episodic migraine (EM) or chronic migraine (CM) and medically-diagnosed depression and/or anxiety who were commercially or Medicare Advantage insured.
November 22, 2019
Purpose: To evaluate the impact of esketamine (ESK) nasal spray in patients with treatment-resistant depression (TRD) and comorbid anxiety.
March 02, 2019
Introduction: Narcolepsy primarily begins in childhood/adolescence. Sodium oxybate (SXB) was evaluated as a treatment for narcolepsy in children/adolescents in a placebo-controlled, randomized-withdrawal study with open-label extension (OLE). The long-term evaluation of depression, anxiety, and…
March 02, 2019
Purpose: To evaluate the effectiveness of a mindfulness-based intervention to reduce the symptoms of depression and anxiety.Background:  Evidence suggests that the combination of mindfulness based therapy and traditional pharmacological therapy provides relief from depressive and anxious symptoms…
December 21, 2017
An anonymous, cross-sectional study was conducted of spine surgeon members of the organization AO Spine North America to determine surgeons' attitudes for measuring pre-operative anxiety among patients and which management techniques were preferred.
December 15, 2017
Pooled data were analyzed post hoc to evaluate whether early improvement with vilazodone was predictive of later response or remission.
January 16, 2017
This poster was presented at the 29th Annual U.S. Psychiatric & Mental Health Congress, held October 21-24, 2016, in San Antonio, Texas.
February 11, 2016
Background: Mental health issues are common among medical student but under-recognized. Rates of depression are higher among medical students compared to the general population, yet few students seek help. Objective: This study examined the difference between perception and reality of medical…
January 22, 2016
Introduction: Generalized anxiety disorder (GAD) may be associated with reduced sexual function. Vilazodone is an SSRI and 5-HT1A receptor partial agonist approved for major depressive disorder in adults. Vilazodone was evaluated in 3 positive double-blind, placebo-controlled trials in GAD; post…
Back to Top